Secondary Logo

Journal Logo

Policies affecting the supply and access of opioid analgesics

a scoping review protocol

Chiu, Kellia1; McDonald, Sally1; Legg, Tess2; Karanges, Emily A.1; Bero, Lisa1

JBI Database of Systematic Reviews and Implementation Reports: October 5, 2019 - Volume Online First - Issue - p
doi: 10.11124/JBISRIR-D-19-00095
SYSTEMATIC REVIEW PROTOCOL: PDF Only
Free
PAP

Objective: This scoping review aims to describe and map the range of evaluated policies that affect the supply and access of opioids for analgesic therapy.

Introduction: There has been increasing concern regarding the rise in opioid analgesic misuse and related harms, including overdose deaths. In response, policies have been developed and implemented to reduce the burden of opioid-related problems, including strategies that aim to affect the supply and/or access of opioid analgesics. However, little is known about the range and nature of these policies, including whether they have been evaluated for effectiveness and how.

Inclusion criteria: Studies to be included must evaluate the effectiveness of policies directly designed to affect the supply and/or access of opioids for analgesic therapy, and measure clinical and health services outcomes quantitatively. Studies that assessed interventions or factors impacting the use of these policies, measured only utilization of the policy itself, and/or measured outcomes regarding attitudes and behaviors towards these policies will be excluded. Literature on policies for the treatment and management of opioid abuse, overdose or addiction will be excluded.

Methods: Multiple databases will be searched including MEDLINE, Embase, PsycINFO, Scopus and Web of Science, using keywords, indexed terms and phrases for the following concepts: opioid, policy, evaluation and clinical context. Each included study will be rated using a modified version of the JBI Levels of Evidence framework. Details on included policies and their assessment will be extracted, and results presented in diagrams and tables.

1Charles Perkins Centre & Sydney Pharmacy School, Faculty of Medicine and Health, the University of Sydney, Sydney, Australia

2Tobacco Control Research Group, University of Bath, Bath, UK

Correspondence: Lisa Bero, lisa.bero@sydney.edu.au

The authors declare no conflicts of interest.

© 2019 by Lippincott williams & Wilkins, Inc.